Targeted Biodistribution of Carboplatin-C Fe Nanocage-Loaded Chitosan Nanoparticles in Rats with Transplanted Liver Cancer
Yue-hua GUO,Wen-hui YAN,Ling GUI,Xue-bin PANG,Fu-rong LI,Shi-yun BAO,Han-xin ZHOU
DOI: https://doi.org/10.3321/j.issn:1001-2494.2009.21.012
2009-01-01
Abstract:OBJECTIVE To observe the biodistribution of carboplatin-Fe@C nanocage-loaded chitosan nanoparticles (C-Fe@CN-CN) injected into hepatic artery under magnetic field in rats. METHODS Eighty normal rats were randomly divided into two groups. Abdominal exposure was carried out through a midline incision, and a cannula was inserted into the hepatic artery and fixed. Carboplatin was injected in Group A. In Group B, C-Fe@CN-CN was injected and the left liver lobe was under 5 000 Gs magnetic field as targeted region for 30 min. At 15,30 min, 1,3,6,12, 24 and 48 h after injuection respectively, the rats were sacrificed. The tissues of targeted liver, non-targeted liver, kidney, spleen, lung and heart were collected. The drug level of tissue was measured by flameless atomic absorption spectrophotometry. The tissue was stained by HE to observe the aggregation of C-Fe@CN-CN. C-Fe@CN-CN was also labeled with 99Tc, and the distribution of radioactivity in vivo was detected by ECT. RESULTS The cTM of caboplatin of targeted liver in Group B (38.47 μg·g~(-1)) was increased by 1.6 times as that of non-targeted liver (14.79 μg·g~(-1)), and 6.7 times as that of liver in Group A (4.98μg·g~(-1))- The concentration of carboplatin of targeted liver at 48 h in Group B (3.11μg·g~（-1）) was increased by 7.9 times as that of non-targeted liver (0.35 μg·g~(-1)), and that in Group A was too low to be detected. The C_(max), of carboplatin in kidney, spleen, and lung in Group B (29.94, 1.54, 1.76 μg·g~(-1)) were significantly lower than those in Group A (37.78, 2.14, 2.34 μg·g~(-1)). The histology examination demonstrated that a lot of C-Fe@CN-CN was accumulated in the interval of liver cells or in the hepatic sinusoid in the magnetic field. There was no the aggregation of C-Fe@CN-CN in non-targeted region. The photograph of radioacticity also showed C-Fe@CN-CN was accumulated in the targeted liver. CONCLUSION C-Fe@CN-CN shows remarkable magnetic target and controlled release in vivo. It can be accumulated among cells in targeted region under magnetic field and slowly release drug to increase the levels of drug, prolong the active time and decrease the Cmax in other organs.